These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 16083620)
21. Lack of interleukin-10 expression could predict poor outcome in patients with stage I non-small cell lung cancer. Soria JC; Moon C; Kemp BL; Liu DD; Feng L; Tang X; Chang YS; Mao L; Khuri FR Clin Cancer Res; 2003 May; 9(5):1785-91. PubMed ID: 12738735 [TBL] [Abstract][Full Text] [Related]
22. The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung. Anton RC; Coffey DM; Gondo MM; Stephenson MA; Brown RW; Cagle PT Mod Pathol; 2000 Nov; 13(11):1167-72. PubMed ID: 11106072 [TBL] [Abstract][Full Text] [Related]
23. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer. Dango S; Sienel W; Schreiber M; Stremmel C; Kirschbaum A; Pantel K; Passlick B Lung Cancer; 2008 Jun; 60(3):426-33. PubMed ID: 18215438 [TBL] [Abstract][Full Text] [Related]
24. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207 [TBL] [Abstract][Full Text] [Related]
25. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification]. Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272 [TBL] [Abstract][Full Text] [Related]
26. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients. Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461 [TBL] [Abstract][Full Text] [Related]
27. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer. Zhang Z; Ma J; Li N; Sun N; Wang C Ann Thorac Surg; 2006 Jul; 82(1):243-8. PubMed ID: 16798222 [TBL] [Abstract][Full Text] [Related]
28. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome. Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306 [TBL] [Abstract][Full Text] [Related]
29. Expression of tissue inhibitor of metalloproteinase-3 (TIMP-3) and its prognostic significance in resected non-small cell lung cancer. Mino N; Takenaka K; Sonobe M; Miyahara R; Yanagihara K; Otake Y; Wada H; Tanaka F J Surg Oncol; 2007 Mar; 95(3):250-7. PubMed ID: 17323339 [TBL] [Abstract][Full Text] [Related]
30. Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in China. Chen XF; Zhang HT; Qi QY; Sun MM; Tao LY Lung Cancer; 2005 Apr; 48(1):69-76. PubMed ID: 15777972 [TBL] [Abstract][Full Text] [Related]
31. [Study of prognostic factors in patients with stage I non-small cell lung cancer]. Jiang ZQ; Jiang GL; Shi DR; Zhang RX; Fu XL; Qian H Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):364-8. PubMed ID: 15312349 [TBL] [Abstract][Full Text] [Related]
32. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival. Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237 [TBL] [Abstract][Full Text] [Related]
33. [Expression of plakoglobin in bronchial carcinomas: incidence and significance for disease outcome]. Passlick B; Pantel K; Stosiek P; Hosch S; Thetter O; Izbicki JR Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():810-3. PubMed ID: 9101995 [TBL] [Abstract][Full Text] [Related]
34. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis. Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752 [TBL] [Abstract][Full Text] [Related]
35. [Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer]. Chen WH; Wang C; Zhang YH; Yang YH; Zhan HY; Zhang LM Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3228-32. PubMed ID: 18399120 [TBL] [Abstract][Full Text] [Related]
36. Clinical implication of cyclin B1 in non-small cell lung cancer. Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Kimura Y; Uchida Y Oncol Rep; 2003; 10(5):1381-6. PubMed ID: 12883711 [TBL] [Abstract][Full Text] [Related]
37. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome. Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284 [TBL] [Abstract][Full Text] [Related]
38. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205 [TBL] [Abstract][Full Text] [Related]